Savient Pharmaceuticals (WKN 813149)
Seite 2 von 3 Neuester Beitrag: 23.07.13 11:20 | ||||
Eröffnet am: | 12.06.09 15:17 | von: iceman78 | Anzahl Beiträge: | 55 |
Neuester Beitrag: | 23.07.13 11:20 | von: Joschi307 | Leser gesamt: | 8.947 |
Forum: | Hot-Stocks | Leser heute: | 1 | |
Bewertet mit: | ||||
Seite: < 1 | | 3 > |
FDA says Savient must address manufacturing issues for gout drug Krystexxa before approval
Obwohl hier kurzfristig über 150% möglich gewsesen sind, siehe Threadperformance, macht die FDA einen Strich durch die Rechnung!
Shares fell $5.89, or 38 percent, to $9.70 in premarket trading.
Schade, auf zum nächsten Zock!
http://finance.yahoo.com/news/...-FDA-rejects-apf-1803540982.html?x=0
MFg
Chali
BOSTON (MarketWatch) -- Shares of Savient Pharmaceuticals SVNT +15.95% jumped 14% to 66 cents a share on Wednesday after the biotech group posted a narrowed second-quarter loss. The stock has risen 8% over the last 30 days but has plunged 70% since the beginning of the year. Earlier this week, Savient adopted a shareholders rights plan to deter a possible hostile takeover by stakeholder Tang Capital Partners. Earlier this year, Tang had asserted that Savient was insolvent. On Wednesday, Savient stated it ended the second quarter with $142.2 million in cash and short-term securities. Savient's revenues largely come from its recently approved gout drug Krystexxa, which had sales of $4 million for the second quarter.
http://www.marketwatch.com/story/...s-report-2012-08-08?siteid=yhoof2
http://seekingalpha.com/article/...nings-call-transcript?source=yahoo
Bin gespannt.
GLTA ;)
Bristol-Myers Squibb Co. and Novartis AG both looked at acquiring Savient and passed because of concern about price, according to two people with knowledge of the matter, who declined to be identified because the talks are private. The board of directors will continue to “evaluate strategic alternatives,” Savient said in a statement today.
http://www.bloomberg.com/news/2010-10-25/...g-company.html?cmpid=yhoo
http://messages.finance.yahoo.com/Stocks_(A_to_Z)/...tof=15&frt=2
Amount beneficially owned:
3113521
Percent of class
4.27%
SC 13G/A amended statement of beneficial ownership 09-10-12
http://investor.savient.com/sec.cfm
http://seekingalpha.com/article/...-rising-from-the-dead?source=yahoo
After Hours: 2,54$
Volumen 13.600
http://www.nasdaq.com/symbol/svnt/after-hours
http://www.biopharmcatalyst.com/ema-calendar/
http://finance.yahoo.com/news/...positive-chmp-opinion-145000794.html